-
2
-
-
0033584440
-
The prevalence of hepatitis C virus in the United Status, 1988 through 1994
-
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus in the United Status, 1988 through 1994. N Engl J Med 1999;341:556-562
-
(1999)
N Engl J Med
, vol.341
, pp. 556-562
-
-
Alter, M.J.1
Kruszon-Moran, D.2
Nainan, O.V.3
-
3
-
-
0036829816
-
Natural history of chronic hepatitis C
-
Seeff LB. Natural history of chronic hepatitis C. Heptology 2002;36:S35-S46
-
(2002)
Heptology
, vol.36
-
-
Seeff, L.B.1
-
4
-
-
0035453089
-
Hepatitis C infection in liver transplantation
-
Charlton M. Hepatitis C infection in liver transplantation. Am J Transplant 2001;1:197-203
-
(2001)
Am J Transplant
, vol.1
, pp. 197-203
-
-
Charlton, M.1
-
5
-
-
0034087303
-
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States
-
Blatt LM, Mutchnick MG, Tong MJ, et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat 2000; 3:196-202
-
(2000)
J Viral Hepat
, vol.3
, pp. 196-202
-
-
Blatt, L.M.1
Mutchnick, M.G.2
Tong, M.J.3
-
6
-
-
0032841858
-
Racial differences in responses to therapy with interferon in chronic hepatitis C
-
Consensus Interferon Study Group
-
Reddy KR, Hoofnagle JH, Tong MJ, et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology 1999;30: 787-793
-
(1999)
Hepatology
, vol.30
, pp. 787-793
-
-
Reddy, K.R.1
Hoofnagle, J.H.2
Tong, M.J.3
-
7
-
-
0037087144
-
Hepatitis C virus prevalence among patients infected with hum an immunodeficiency virus: A cross-sectional analysis of the US adult
-
AIDS Clinical Trial Group
-
Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C virus prevalence among patients infected with hum an immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trial Group. Clin Infec Dis 2002;34:831-837
-
(2002)
Clin Infec Dis
, vol.34
, pp. 831-837
-
-
Sherman, K.E.1
Rouster, S.D.2
Chung, R.T.3
-
8
-
-
0037418113
-
Hepatitis C in the HIV-infected person
-
Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003;138:197-207
-
(2003)
Ann Intern Med
, vol.138
, pp. 197-207
-
-
Sulkowski, M.S.1
Thomas, D.L.2
-
9
-
-
0028566409
-
Clinical and histologic predictors of response to interferon-alpha in patients with chronic hepatitis C viral infection
-
Lam NP, DeGuzman LJ, Pitrak D, et al. Clinical and histologic predictors of response to interferon-alpha in patients with chronic hepatitis C viral infection. Dig Dis Sci 1994; 39:2660-2664
-
(1994)
Dig Dis Sci
, vol.39
, pp. 2660-2664
-
-
Lam, N.P.1
DeGuzman, L.J.2
Pitrak, D.3
-
10
-
-
0031025974
-
Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C
-
Lam NP, Pitrak D, Speralakis R, et al. Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C. Dig Dis Sci 1997;42:178-185
-
(1997)
Dig Dis Sci
, vol.42
, pp. 178-185
-
-
Lam, N.P.1
Pitrak, D.2
Speralakis, R.3
-
11
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
12
-
-
0032475822
-
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy
-
Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science 1998;282:103-107
-
(1998)
Science
, vol.282
, pp. 103-107
-
-
Neumann, A.U.1
Lam, N.P.2
Dahari, H.3
-
13
-
-
0035991450
-
Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy
-
Rosen HR, Ribeiro RR, Weinberger L, et al. Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy. J Hepatol 2002;37: 124-130
-
(2002)
J Hepatol
, vol.37
, pp. 124-130
-
-
Rosen, H.R.1
Ribeiro, R.R.2
Weinberger, L.3
-
14
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-965
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
|